Methyl Alcohol

Methyl Alcohol

SCHEMBL718774

CCOc1ccc(O)cc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1.CO

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.67
DRD2 P14416 2/20 0.67
HTR2A P28223 2/20 0.67
ABCB11 O95342 1/20 0.67
CHRM2 P08172 1/20 0.67
ADRA2A P08913 1/20 0.67
CHRM1 P11229 1/20 0.67
ADRA2B P18089 1/20 0.67
ADRA2C P18825 1/20 0.67
DRD1 P21728 1/20 0.67
DRD4 P21917 1/20 0.67
ACHE P22303 1/20 0.67
SLC6A2 P23975 1/20 0.67
HTR2C P28335 1/20 0.67
SLC6A4 P31645 1/20 0.67
CCKBR P32239 1/20 0.67
ADRA1A P35348 1/20 0.67
HRH1 P35367 1/20 0.67
OPRM1 P35372 1/20 0.67
DRD3 P35462 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL718326 0.92 DRD2 (0.69) HTR1ADRD2HTR2AABCB11CHRM2
Methyl Alcohol SCHEMBL718775 0.92 HTR1A (0.71) HTR1ADRD2HTR2AABCB11CHRM2
SCHEMBL1545055 0.88 ABCB11 (0.86) HTR1ADRD2HTR2AABCB11CHRM2
Methyl Alcohol SCHEMBL929694 0.84 ABCB11 (0.66) HTR1ADRD2HTR2AABCB11CHRM2
Methyl Alcohol SCHEMBL142049 0.84 ABCB11 (0.66) HTR1ADRD2HTR2AABCB11CHRM2
Methyl Alcohol SCHEMBL718327 0.84 HTR1A (0.76) HTR1ADRD2HTR2AABCB11CHRM2
Alcohol SCHEMBL142048 0.84 DRD2 (0.66) HTR1ADRD2HTR2AABCB11CHRM2
SCHEMBL9101152 0.84 HTR1A (0.68) HTR1ADRD2HTR2AABCB11CHRM2
SCHEMBL22149696 0.84 DRD2 (0.76) HTR1ADRD2HTR2AACHEHTR2C
Alcohol SCHEMBL8713382 0.83 HTR1A (0.69) HTR1ADRD2HTR2AADRA2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458507-B1 Antipsychotic treatment based on SNP genotype VANDA PHARMACEUTICALS, INC. (US) 2016-10-04 US claimed
US-20160265060-A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE VANDA PHARMACEUTICALS, INC. 2016-09-15 US claimed
US-20100292211-A1 ANTIPSYCHOTIC TREATMENT BASED ON SNP GENOTYPE VANDA PHARMACEUTICALS, INC. 2010-11-18 US claimed
US-20100249188-A1 PREDICTION OF QT PROLONGATION BASED ON SNP GENOTYPE VANDA PHARMACEUTICALS, INC. 2010-09-30 US claimed
US-9243295-B2 Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype Vanda Pharmaceutical, Inc. (US) 2016-01-26 US disclosed
US-9057104-B2 Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype VANDA PHARMACEUTICALS, INC. (US) 2015-06-16 US disclosed
US-20120053207-A1 ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE VANDA PHARMACEUTICALS, INC. (US) 2012-03-01 US disclosed